Senior Director, Translational Pathology

Job Summary

The Sr Director, Translational Pathology will oversee capabilities transformation and translational pathology strategy across multiple drug programs and indications. They will work to bring new technologies and approaches to patient selection and pharmacodynamic biomarkers for Oncology and Specialty Medicine programs. Responsibilities include a focus on digital pathology investigations, exploratory biomarker investigations including integration of pathology datasets with broader multi-omic analyses, and technical oversight for CDx programs.

The successful candidate will work effectively in a highly collaborative environment, aligning with key counterparts within Pathology, Translational Science, Bioinformatics, and Companion Diagnostics in the US and Japan. The position includes direct report management.

• Design and build internal digital pathology capabilities and support data generation for translational pathology evaluations across the portfolio. Develop and manage partnerships, largely focused on digital pathology, to support design and implementation of translational pathology plans.
• Effectively interface with cross functional partners to drive the translational pathology strategic direction and support data generation for assigned assets, with a focus on the design and implementation of translational pathology plans.
• Provide scientific input for assay development and design of pre-clinical assessments to enable successful translational strategies and implementation designs.
• Provide expertise to the Daiichi Sankyo Global Research & Development organization to ensure access to state-of-the-art thinking on appropriate translational pathology strategies, evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to proposed business plans.
• Communicate with portfolio leaders in Clinical Development, Discovery, QCP, CDx, RA, MA or other relevant functions to ensure effective integration of translational pathology strategy into broader Translational/Program strategies

Education Qualifications

• MD MD or MD PhD with Anatomic Pathology board certification required required and Clinical Pathology board certification preferred

Experience Qualifications

• 10 or More Years 10 or more years of post-doctoral and relevant industry experience, preferably biopharmaceutical, with expertise in pathology-driven translational research, biomedical leadership and human translational research in clinical trials required.
• 4 or More Years 5 or more years of direct digital and computational pathology experience, ideally focused on biomarker discovery, translational pathology, or biomarker validation required
• 4 or More Years 3+ years of direct pharmaceutical industry experience required
• Expansive experience with digital/computational pathology technologies and translational research. Extensive experience in the discovery, characterization and utilization of innovative translational strategies across the continuum of preclinical and clinical stages required.
• 4 or More of direct management experience and extensive experience leading through influence. preferred
• Experience/knowledge in companion diagnostics device development, including digital/computational solutions preferred.

Ability to travel up to 10% of the time. global travel

Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.

USD$ - USD$